Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
The search for effective Alzheimer’s treatments is emerging as a promising market, capturing the attention of major ...
While the Alzheimer’s market is projected to experience strong growth throughout the forecast period across the 8MM, unmet ...
There’s intriguing news today about a technology that could improve treatment in people with Alzheimer’s. It uses sound waves ...
With an estimated 6.9 million Americans aged 65 and older currently living with Alzheimer’s disease, the road to a cure seems ...
The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS. Regulators are due to ...
Axsome Therapeutics said it would submit its Alzheimer’s disease treatment for FDA approval despite mixed results from two ...
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...
For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...
A groundbreaking study reveals that concussions and repetitive head injuries in sports could trigger latent viruses in the ...